JP2023545274A5 - - Google Patents
Info
- Publication number
- JP2023545274A5 JP2023545274A5 JP2023521512A JP2023521512A JP2023545274A5 JP 2023545274 A5 JP2023545274 A5 JP 2023545274A5 JP 2023521512 A JP2023521512 A JP 2023521512A JP 2023521512 A JP2023521512 A JP 2023521512A JP 2023545274 A5 JP2023545274 A5 JP 2023545274A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2020/119834 | 2020-10-07 | ||
| CN2020119834 | 2020-10-07 | ||
| PCT/CN2021/122530 WO2022073469A1 (en) | 2020-10-07 | 2021-10-07 | Compounds and methods of treating cancers |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023545274A JP2023545274A (ja) | 2023-10-27 |
| JPWO2022073469A5 JPWO2022073469A5 (https=) | 2024-10-16 |
| JP2023545274A5 true JP2023545274A5 (https=) | 2024-10-16 |
Family
ID=81125595
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023521512A Pending JP2023545274A (ja) | 2020-10-07 | 2021-10-07 | 癌を処置する化合物および方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240050428A1 (https=) |
| EP (1) | EP4225749A4 (https=) |
| JP (1) | JP2023545274A (https=) |
| CN (1) | CN116583509A (https=) |
| WO (1) | WO2022073469A1 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024504932A (ja) | 2021-01-13 | 2024-02-02 | モンテ ローザ セラピューティクス， インコーポレイテッド | イソインドリノン化合物 |
| AU2022271290A1 (en) | 2021-05-07 | 2023-11-23 | Kymera Therapeutics, Inc. | Cdk2 degraders and uses thereof |
| EP4353720A4 (en) * | 2021-10-01 | 2025-05-14 | Nextgen Bioscience Co., Ltd. | NOVEL PIPERIDINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION FOR INHIBITING AUTOTAXIN COMPRISING IT |
| US20250221988A1 (en) * | 2022-04-06 | 2025-07-10 | Cullgen (Shanghai), Inc. | Compounds and methods of treating cancers |
| US20250361239A1 (en) * | 2022-06-10 | 2025-11-27 | Zhuhai Yufan Biotechnologies Co., Ltd. | Protein degraders and uses thereof |
| WO2024015855A1 (en) * | 2022-07-13 | 2024-01-18 | Monte Rosa Therapeutics, Inc. | COMBINATION THERAPY COMPRISING GSPT1-DIRECTED MOLECULAR GLUE DEGRADERS AND PI3K/AKT/mTOR PATHWAY INHIBITORS |
| EP4570792A1 (en) * | 2022-08-10 | 2025-06-18 | Gluetacs Therapeutics (Shanghai) Co., Ltd. | Compound based on isoindoline-substituted glutarimide backbone and use thereof |
| CN115636811A (zh) * | 2022-08-17 | 2023-01-24 | 成都分迪药业有限公司 | 异吲哚啉苄胺衍生物的合成方法 |
| CN120303264A (zh) | 2022-09-09 | 2025-07-11 | 医诺康治疗公司 | CK1α和双重CK1α/GSPT1降解化合物 |
| WO2024099441A1 (en) * | 2022-11-11 | 2024-05-16 | Jingrui Biopharma (Shandong) Co., Ltd. | Bromodomain and extra-terminal (bet) protein degrader |
| JP2026500305A (ja) | 2022-12-16 | 2026-01-06 | アストラゼネカ・アクチエボラーグ | ２，６，９三置換プリン |
| JP2026511128A (ja) * | 2023-03-21 | 2026-04-10 | シャンハイ ヘリオソン ファーマシューティカル カンパニー リミテッド | イソインドリン誘導体、ベンゾインドール誘導体及びそれらの使用 |
| WO2025179161A1 (en) | 2024-02-21 | 2025-08-28 | Innovo Therapeutics, Inc. | Protein degrading compounds |
| WO2025231420A1 (en) * | 2024-05-03 | 2025-11-06 | Albert Einstein College Of Medicine | Small molecule degraders of soluble epoxide hydrolase |
| WO2026021557A1 (zh) * | 2024-07-26 | 2026-01-29 | 上海超阳药业有限公司 | 苯并吲哚衍生物的药物组合物、制备方法及用途 |
| CN119059953A (zh) * | 2024-08-27 | 2024-12-03 | 吉林大学 | 一种快捷合成1-(乙基磺酰基)氮杂环丁烷-3-酮的方法 |
| WO2026061491A1 (zh) * | 2024-09-20 | 2026-03-26 | 上海超阳药业有限公司 | 一种苯并吲哚衍生物的晶型、盐型及其制备方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018011847A1 (ja) * | 2016-07-11 | 2018-01-18 | オリンパス株式会社 | 内視鏡処置具 |
| CA3043938A1 (en) * | 2016-12-21 | 2018-06-28 | Biotheryx, Inc. | Thienopyrrole derivatives for use in targeting proteins, compositions, methods, and uses thereof |
| US10406165B2 (en) * | 2017-03-14 | 2019-09-10 | Biotheryx, Inc. | Compounds targeting proteins, compositions, methods, and uses thereof |
| EP4201399A3 (en) * | 2017-06-30 | 2023-08-09 | Celgene Corporation | Compositions and methods of use of 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl) methyl) -2,2-difluoroacetamide |
| TWI793151B (zh) * | 2017-08-23 | 2023-02-21 | 瑞士商諾華公司 | 3-(1-氧異吲哚啉-2-基)之氫吡啶-2,6-二酮衍生物及其用途 |
| CN109422753B (zh) * | 2017-09-03 | 2021-12-31 | 上海美志医药科技有限公司 | 一类具有抑制并降解酪氨酸蛋白激酶jak1或jak2活性的化合物 |
| CN109912655B (zh) * | 2017-12-13 | 2021-12-10 | 上海科技大学 | Alk蛋白降解剂及其抗肿瘤应用 |
| AU2019284608A1 (en) * | 2018-06-13 | 2020-12-17 | Biotheryx, Inc. | Aminoamide compounds |
| CN112601751B (zh) * | 2018-06-13 | 2024-04-02 | 拜欧斯瑞克斯公司 | 稠合噻吩化合物 |
| MX2021001957A (es) * | 2018-08-22 | 2021-07-15 | Cullgen Shanghai Inc | Compuestos de degradacion y metodos de uso del receptor de tropomiosina quinasa (trk). |
| CN113646002A (zh) * | 2019-02-27 | 2021-11-12 | 上海睿跃生物科技有限公司 | 环amp反应元件结合蛋白(cbp)和/或300kda腺病毒e1a结合蛋白(p300)降解化合物和使用方法 |
| US20230093099A1 (en) * | 2019-04-02 | 2023-03-23 | Cullgen (Shanghai), Inc. | Compounds and methods of treating cancers |
| JP2022533260A (ja) * | 2019-05-24 | 2022-07-21 | バイオセリックス， インコーポレイテッド | タンパク質を標的とする化合物及びその医薬組成物並びにそれらの治療的応用 |
| EP4041231A1 (en) * | 2019-10-09 | 2022-08-17 | Monte Rosa Therapeutics AG | Isoindolinone compounds |
-
2021
- 2021-10-07 CN CN202180082392.9A patent/CN116583509A/zh active Pending
- 2021-10-07 EP EP21876987.5A patent/EP4225749A4/en active Pending
- 2021-10-07 JP JP2023521512A patent/JP2023545274A/ja active Pending
- 2021-10-07 US US18/248,035 patent/US20240050428A1/en active Pending
- 2021-10-07 WO PCT/CN2021/122530 patent/WO2022073469A1/en not_active Ceased